Citations 1

MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design

Neurodegenerative Disease Management | November 24, 2021 | Volume: 11 | Issue: 6 | Pages: 431-443

10.2217/nmt-2021-0042 | PMID 34816762